Editorial: Organ crosstalk in the pathophysiology and treatment of type-2 diabetes
Estela Lorza-Gil,
Estela Lorza-Gil,
Estela Lorza-Gil,
Bilgen Ekim,
Bilgen Ekim,
Gencer Sancar,
Gencer Sancar,
Gencer Sancar
Affiliations
Estela Lorza-Gil
Department of Internal Medicine IV, Division of Endocrinology, Diabetology and Nephrology, University Hospital Tübingen, Tübingen, Germany
Estela Lorza-Gil
Institute for Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany
Estela Lorza-Gil
German Center for Diabetes Research (DZD e. V.), Neuherberg, Germany
Bilgen Ekim
German Center for Diabetes Research (DZD e. V.), Neuherberg, Germany
Bilgen Ekim
Joint Heidelberg-Institute for Diabetes and Cancer (IDC) Helmholtz Center Munich Translational Diabetes Program, Department of Internal Medicine, Heidelberg University Hospital, Heidelberg, Germany
Gencer Sancar
Department of Internal Medicine IV, Division of Endocrinology, Diabetology and Nephrology, University Hospital Tübingen, Tübingen, Germany
Gencer Sancar
Institute for Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany
Gencer Sancar
German Center for Diabetes Research (DZD e. V.), Neuherberg, Germany